Interferon and the fear of needles: A case report

Gastroenterology Nursing

Volumn 34, Issue 5, 2011, Pages 384-388

  López, Maria ^a   Moreno, Laura ^a   Dosal, Angelina ^a   Pujol, Marta Maria ^a   Vergara, Mercedes ^a   Gil, Montserrat ^a  

^a Day Care Hospital of Digestive Diseases Department   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2B; RECOMBINANT PROTEIN; RIBAVIRIN;

ADULT; CASE REPORT; DRUG COMBINATION; FEAR; FEMALE; HEPATITIS C; HUMAN; METHODOLOGY; NEEDLE; NURSE PATIENT RELATIONSHIP; PATIENT EDUCATION; PHOBIA; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; DRUG THERAPY, COMBINATION; FEAR; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; NEEDLES; NURSE-PATIENT RELATIONS; PATIENT EDUCATION AS TOPIC; PHOBIC DISORDERS; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 80053907837     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/SGA.0b013e31822c3a3a     Document Type: Article

References (29)

1. Bodenreider, O. (2004). The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Research, 32, 267-270.
2. Borrás-Blasco, J., Garcia-Perez, A., Rosique-Robles, J. D., Casterá M. D., & Abad, F. J. (2010). Acceptability of switching adali-mumab from a prefilled syringe to an autoinjection pen. Expert Opinion on Biological Therapy, 10(3), 301-307.
3. Bruguera, M., & Forns, X. (2006). Hepatitis C in Spain. Medicina Clinica (Barc), 127, 113-117. (Pubitemid 44114247)
4. Clark, J. (1998, September 30). The international classification for nursing practice project. Online Journal of Issues in Nursing, 3(2). Retrieved from http://www.nursingworld.org/MainMenuCategories/ANAMarketplace/ ANAPeriodicals/OJIN/TableofContents/Vol31998/No2Sept1998/ TheInternationalClassificationForNursingPractice Project.aspx
5. Coenen, A., McNeil, B., Bakken, S., Bicford, C., & Warren, J. (2001). Toward comparable nursing data: American Nurses Association criteria for data sets, classification systems, and nomenclatures. Computers in Nursing, 19(6), 240-246. (Pubitemid 33771802)
6. Cox, A. C., & Fallowfield, L. J. (2007). After going through chemotherapy I can't see another needle. European Journal of Oncology Nursing, 11(1), 43-48.
7. Dan, A. A., Martin, L. M., Crone, C., Ong, J. P. , Farmer, D. W., Wise, T., . Younossi, Z. M. (2006). Depression, anemia and health-related quality of life in chronic hepatitis C. Journal of Hepatology, 44, 491-498. (Pubitemid 43227873)
8. Dienstag, J. L., & McHutchison, J. G. (2006). American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology, 130, 231-264. (Pubitemid 43049856)
9. Elizalde, I., Iñarrairegui, M., Rodríguez, C., & Zozaya, J. M. (2004). Tratamiento de la infección crónica por VHC [Treatment of chronic HCV infection]. An Sist Sanit Navar, 27(2), 81-91.
10. Freedman, S. M., Cox, D., & Rosebrough, T. (2008). A prospective baseline versus on-treatment study assessing patient perceptions of using a smaller needle when injecting intramuscular interfer-on beta-1 a (Avonex). Journal of Neuroscience Nursing, 40(6), 350-355.
11. Fried, M. W. , Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Goncales, F. L., Jr., Yu J. (2002). Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine, 347, 975-982.
12. Gervais, A., Boyer, N., & Marcellin, P. (2001). Tolerability of treatments for viral hepatitis. Drug Safety, 24, 375-384. (Pubitemid 32417536)
13. Goossen, W. , Epping, P., Van den Heuvel, W. T., Frederiks, C., & Hasman, A. (2000). Development of the Nursing Minimum Data Set for the Netherlands: identifications of categories and items. Journal of Advanced Nursing, 31(3), 536-547.
14. Hadziyannis, S. J., Sette, H., Jr., Morgan, T. R., Balan, V. , Diago, M., Marcellin, P. , PEGASYS International Study Group. (2004). Peginterferon- alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine, 140, 346-355.
15. Hyun, S., & Park, H. A. (2002). Cross-mapping the ICNP with NANDA, HHCC, Omaha System and NIC for unified nursing language system development. International Classification for Nursing Practice. International Council of Nurses. North American Nursing Diagnosis Association. Home Health Care Classification. Nursing Interventions Classification. International Nursing Review, 49(2), 99-110.
16. Johnson, M., Bulechek, G., McCloskey, J., Maas, M. L. & Butcher, H. K. (Eds.). (2007). Interrelaciones NANDA, NOC y NIC: Diagnósticos enfermeros, resultados e intervenciones [Inter-relationships between NANDA, NOC and NIC: nursing diagnoses, outcomes and interventions]. Madrid, Spain: Elsevier.
17. Kettwich, S. C., Sibbitt, W. L., Jr., Brandt, J. R., Johnson, C. R., Wong, C. S., & Bankhurst, A. D. (2007). Needle phobia and stress-reducing medical devices in pediatric and adult chemotherapy patients. Journal of Pediatric Oncology Nursing, 24(1), 20-38.
18. Manns, M. P. , McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Albrecht, J. K. (2001). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet, 358, 958-965. (Pubitemid 32913521)
19. McCloskey, J. C., & Bulechek, G. M. (Eds.). (2005). Clasificación de intervenciones de enfermería (CIE) [Nursing interventions classification (NIC)]. Madrid, Spain: Elsevier.
20. McHutchison, J. G., Manns, M., Patel, K., Poynard, T., Lindsay, K. L., Trepo, C., International Hepatitis Interventional Therapy Group. (2002). Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology, 123, 1061-1069.
21. Mohr, D. C., Cox, D., & Merluzzi, N. (2005). Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications. Multiple Sclerosis, 11(2), 182-185. (Pubitemid 40403257)
22. Moorhead, S., Johnson, M., Mass, M. L., & Swonson, E. (Eds.). (2009). Clasificacion de resultados de Enfermeria (NOC). Barcelona, Spain: Elsevier.
23. Mumford, O. (2004). Patient tips from industry. Coping with needle phobia. Diabetes Educator, 30(2), 174.
24. NANDA-I. (2008). Diagnósticos enfermeros: Definiciones y Clasificación, 2007-2008 [Nursing diagnoses. Definitions and classification]. Madrid, Spain: Elsevier.
25. Poll, R. (2009). The role of the community nurse in hepatitis C diagnosis and treatment. British Journal of Community Nursing, 14(7), 292-296.
26. Rogers, G., & Campbell, L. (2003). Hepatitis C virus: its prevalence, implications and management. Nursing Times, 99(50), 30-31.
27. Smalley, A. (1999). Needle phobia. Pediatric Nursing, 11(2), 17-20.
28. Strader, D. B., Wright, T., Thomas, D. L. & Seeff, L. B. (2004). Diagnosis, management, and treatment of hepatitis C. Hepatology, 39(4), 1147-1171. (Pubitemid 38428955)
29. Vergara, M., Gallach, M., Dalmau, B., Gil, M., Miquel, M., Rudi, N., Real, J. (2008). Results of pegylated interferon and ribavirina for the treatment of chronic hepatitis C in clinical practice: A 5-year experience. Gastroenterology & Hepatology, 31(5), 274-279. (Pubitemid 351670887)